BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6264184)

  • 1. [Transcatheter arterial embolization therapy for hepatoma--assessment in blood chemistry (author's transl)].
    Yamada R; Nakatsuka H; Nakamura K; Sato M; Itami M; Kobayashi N; Tamaoka K; Oda J; Minakuchi K; Onoyama Y; Kanno T; Marumo T; Monna T; Yamamoto S
    Nihon Shokakibyo Gakkai Zasshi; 1981 Feb; 78(2):214-21. PubMed ID: 6264184
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum and tissue GOT GPT activities and GOT isoenzymes in human hepatocellular carcinoma and in 3'-me-dab' induced rat hepatoma (author's transl)].
    Arishima T
    Nihon Shokakibyo Gakkai Zasshi; 1978 Mar; 75(3):324-36. PubMed ID: 207911
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury.
    Suou T; Yamada S; Kobayashi J; Hoshino U; Nishimuki E; Kawasaki H
    Hepatology; 1993 Oct; 18(4):809-15. PubMed ID: 7691706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Primary liver cancer. A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases.
    al-Sarraf M; Go TS; Kithier K; Vaitkevicius VK
    Cancer; 1974 Feb; 33(2):574-82. PubMed ID: 4360057
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma.
    Seki T; Tamai T; Nakagawa T; Imamura M; Nishimura A; Yamashiki N; Ikeda K; Inoue K
    Cancer; 2000 Sep; 89(6):1245-51. PubMed ID: 11002219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transcatheter embolization of renal adenocarcinoma: serum enzyme activities and isoenzyme patterns following embolization (author's transl)].
    Shoji R; Machida T; Masuda F; Sasaki T; Chen Z; Okazaki T; Tashiro K
    Nihon Hinyokika Gakkai Zasshi; 1979 Feb; 70(2):207-13. PubMed ID: 439525
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma.
    Shimokawa Y; Okuda K; Kubo Y; Kaneko A; Arishima T; Nagata E; Hashimoto M; Sawa Y; Nagasaki Y; Kojiro M; Sakamoto K; Nakashima T
    Cancer; 1977 Jul; 40(1):319-24. PubMed ID: 195707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between serum enzymes and serum unsaturated vitamin B12 binding proteins in primary liver carcinoma.
    Osifo BO; Ayoola A; Parmentier Y; Gerard P; Nicolas JP
    Enzyme; 1988; 39(3):161-6. PubMed ID: 2837386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal vein embolization and stem cell administration.
    Ozkan F; Peynircioglu B; Cil BE
    Radiology; 2008 Feb; 246(2):646; author reply 646-7. PubMed ID: 18227559
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated alpha-fetoprotein levels in hepatocellular carcinoma.
    Yao FY
    Am J Gastroenterol; 1999 Nov; 94(11):3387. PubMed ID: 10566766
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in serum enzyme activity after transcatheter arterial embolization for hepatic neoplasm.
    Yoshikawa C; Shimojo N; Naka K; Akai T; Okuda K; Kaminou T; Yamada T; Nakatsuka H
    Clin Biochem; 1987 Dec; 20(6):435-40. PubMed ID: 2830050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma.
    Khan KN; Nakata K; Kusumoto Y; Shima M; Ishii N; Koji T; Nagataki S
    Cancer Res; 1991 Oct; 51(20):5667-71. PubMed ID: 1717151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
    Collazos J
    Cancer; 1992 Sep; 70(5):1202-3. PubMed ID: 1381271
    [No Abstract]   [Full Text] [Related]  

  • 14. The value of liver function tests in hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Thambyrajah V; Timor J
    Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manifestations and prognosis of carcinoma of the liver.
    Malt RA; Van Vroonhoven TJ; Kakumoto Y
    Surg Gynecol Obstet; 1972 Sep; 135(3):361-4. PubMed ID: 4340970
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transcatheter arterial embolization therapy in hepatomas--assessed by computed tomography (author's transl)].
    Yamada R; Nakatsuka H; Nakamura K; Sato M; Tamaoka K; Itami M; Kobayashi N; Takashima S; Oda J; Minakuchi K; Yamaguchi S; Onoyama Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Jan; 41(1):15-23. PubMed ID: 6262710
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum -fetoprotein in hepatoma patients after liver transplantation.
    Alpert E; Starzl TE; Schur PH; Isselbacher KJ
    Gastroenterology; 1971 Aug; 61(2):144-8. PubMed ID: 4104962
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transcatheter arterial embolization therapy (author's transl)].
    Yamada R; Nakamura K
    Nihon Rinsho; 1982; 40(1):183-90. PubMed ID: 6283203
    [No Abstract]   [Full Text] [Related]  

  • 19. [The clinical course of Reye's syndrome (author's transl)].
    Mutz I; Grubbauer HM; Weikmann E; Müller W
    Wien Klin Wochenschr; 1974 Dec; 86(24):745-9. PubMed ID: 4439932
    [No Abstract]   [Full Text] [Related]  

  • 20. Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization.
    Iwasa S; Ikeda M; Okusaka T; Ueno H; Morizane C; Nakachi K; Mitsunaga S; Kondo S; Hagihara A; Shimizu S; Satake M; Arai Y
    Jpn J Clin Oncol; 2011 Jun; 41(6):770-5. PubMed ID: 21459893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.